Interview: Pressures On US Generics Industry Go Beyond Current Price Squeeze

Generics firms in the US must fight back against brand industry attempts to thwart competition as well as regulatory obstacles looming on the horizon, while continuing to grapple with ongoing price erosion, says AAM president and CEO Chip Davis.

IV1812_Generics-01_Price-Pressures_1200.jpg
'Significant pressures threaten the future sustainability of competitive generic and biosimilar markets in the US' • Source: Shutterstock

More from Business

More from Generics Bulletin